Glutamic Acid News and Research

RSS
Serologic status and autoimmune cerebellar ataxia type predict treatment response

Serologic status and autoimmune cerebellar ataxia type predict treatment response

People who eat high protein foods have lower blood pressure and arterial stiffness

People who eat high protein foods have lower blood pressure and arterial stiffness

Discovery may have opened up new frontier in fight against breast cancer

Discovery may have opened up new frontier in fight against breast cancer

Pre-POINT trial raises hope for Type 1 diabetes prevention

Pre-POINT trial raises hope for Type 1 diabetes prevention

Study highlights the treatable causes of cerebellar ataxias

Study highlights the treatable causes of cerebellar ataxias

Protein Sciences earns Frost & Sullivan 2013 Global New Product Innovation Award

Protein Sciences earns Frost & Sullivan 2013 Global New Product Innovation Award

Research findings may lead to novel target for chemoresistant cancer cells

Research findings may lead to novel target for chemoresistant cancer cells

Schizophrenia focus narrowed to dentate gyrus

Schizophrenia focus narrowed to dentate gyrus

Researchers demonstrate advantages of HOPE fixation strategy

Researchers demonstrate advantages of HOPE fixation strategy

New drug is effective against superbug MRSA

New drug is effective against superbug MRSA

Genetic variant linked with increased risk of CHD in type 2 diabetic patients

Genetic variant linked with increased risk of CHD in type 2 diabetic patients

Researchers identify genetic locus associated with increased risk of CHD in type 2 diabetes patients

Researchers identify genetic locus associated with increased risk of CHD in type 2 diabetes patients

Autoantibody aids identification of hyperexcitability disorders

Autoantibody aids identification of hyperexcitability disorders

Changes in endocannabinoid system may have important implications for psychiatric disorders

Changes in endocannabinoid system may have important implications for psychiatric disorders

TrialNet presents Diamyd Phase II study results on type 1 diabetes at ADA 2011

TrialNet presents Diamyd Phase II study results on type 1 diabetes at ADA 2011

Diamyd Medical to terminate US DiaPrevent Phase III study for type 1 diabetes

Diamyd Medical to terminate US DiaPrevent Phase III study for type 1 diabetes

Neurologix reports new results from NLX-P101 Phase 2 trial against Parkinson's disease

Neurologix reports new results from NLX-P101 Phase 2 trial against Parkinson's disease

Diamyd European Phase III study in diabetes does not meet primary endpoint

Diamyd European Phase III study in diabetes does not meet primary endpoint

Neurologix presents NLX-P101 Phase 2 trial in Parkinson's disease at 10th INS World Congress

Neurologix presents NLX-P101 Phase 2 trial in Parkinson's disease at 10th INS World Congress

Diamyd Medical announces European Phase III study results in type 1 diabetes

Diamyd Medical announces European Phase III study results in type 1 diabetes